Mild non-BH4-deficient hyperphenylalaninemia (HPANBH4) is an autosomal recessive disorder characterized by increased serum phenylalanine usually detected by newborn screening and associated with highly variable neurologic defects, including movement abnormalities and intellectual disability. Laboratory analysis shows dopamine and serotonin deficiencies in the cerebrospinal fluid, and normal BH4 metabolism. Evidence suggests that treatment with neurotransmitter precursors can lead to clinical improvement or even prevent the neurologic defects if started in infancy (summary by {1:Anikster et al., 2017}).
Comprehensive, easy-to-understand information about this condition
Checking for content...
immunodeficiency-centromeric instability-facial anomalies syndrome
MONDO:0000133
hypercalcemia, infantile
MONDO:0000212
disorder of methionine catabolism
MONDO:0000351
inborn serine deficiency
MONDO:0000421
cerebral creatine deficiency syndrome
MONDO:0000456
Ochoa syndrome
MONDO:0000463